Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anca M Avram

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Nuclear Medicine Technology|September 5, 2020
SNMMI Procedure Standard for Scintigraphy for Differentiated Thyroid CancerTwyla B Bartel Chair, Samuel Magerefteh, Anca M Avram, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 31, 2017
Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin LymphomaPeter L Roberson, Lauren B Smith, Meredith A Morgan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modelingYuni K Dewaraja, Matthew J Schipper, Peter L Roberson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 9, 2019
EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphyLuca Giovanella, Anca M Avram, Ioannis Iakovou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2022
SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated VersionAnca M Avram, Luca Giovanella, Bennett Greenspan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2014
Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab RadioimmunotherapyYuni K Dewaraja, Matthew J Schipper, Jincheng Shen, et al.
Thyroid : Official Journal of the American Thyroid Association|March 23, 2011
Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association, James C Sisson, John Freitas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2020
Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid CancerKevin J Donohoe, Jennifer Aloff, Anca M Avram, et al.
Thyroid : Official Journal of the American Thyroid Association|October 3, 2014
Potential risks of excess iodine ingestion and exposure: statement by the american thyroid association public health committeeAngela M Leung, Anca M Avram, Alina V Brenner, et al.
Thyroid : Official Journal of the American Thyroid Association|April 1, 2021
A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid CancerSeza A Gulec, Sukhjeet Ahuja, Anca M Avram, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Nuclear Medicine Technology|September 5, 2020
SNMMI Procedure Standard for Scintigraphy for Differentiated Thyroid CancerTwyla B Bartel Chair, Samuel Magerefteh, Anca M Avram, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 31, 2017
Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin LymphomaPeter L Roberson, Lauren B Smith, Meredith A Morgan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modelingYuni K Dewaraja, Matthew J Schipper, Peter L Roberson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 9, 2019
EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphyLuca Giovanella, Anca M Avram, Ioannis Iakovou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2022
SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated VersionAnca M Avram, Luca Giovanella, Bennett Greenspan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2014
Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab RadioimmunotherapyYuni K Dewaraja, Matthew J Schipper, Jincheng Shen, et al.
Thyroid : Official Journal of the American Thyroid Association|March 23, 2011
Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association, James C Sisson, John Freitas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2020
Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid CancerKevin J Donohoe, Jennifer Aloff, Anca M Avram, et al.
Thyroid : Official Journal of the American Thyroid Association|October 3, 2014
Potential risks of excess iodine ingestion and exposure: statement by the american thyroid association public health committeeAngela M Leung, Anca M Avram, Alina V Brenner, et al.
Thyroid : Official Journal of the American Thyroid Association|April 1, 2021
A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid CancerSeza A Gulec, Sukhjeet Ahuja, Anca M Avram, et al.
Pageof 8